The company is outgrowing its own explanations: management keeps telling investors the reported numbers are not the busi
The model's full reasoning — Q2 2022 call → NO我们根据提供的财报电话会议记录,判断管理层是否传达出“报告期结果不代表公司当前实际运营状况”这一信息。关键点:管理层是否反复或实质性地表明,刚报告的数字描述的是已被当前业务超越的过去状态。 分析内容: - 管理层提到DSA(发现与安全评估)业务增长强劲,但指出“Discovery业务决策时间延长”,而安全评估业务积压订单远超去年,且价格更高。 - 管理层强调“安全评估业务的需求和积压订单强劲”,并说“我们感觉很好”,但未明确说报告期数字落后于当前业务。 - 关于CDMO业务,管理层承认收入低于预期,但表示正在整合、重建销售团队、进行设施扩建,并提到EMA审计成功,但这些都是为未来做准备,并非当前已实现。 - 管理层提到“我们正在为未来增长进行投资”,但未明确说报告期数字已过时。 - 管理层在回答关于2023年展望时,表示“现在说还为时过早”,并提到宏观环境变化,但未明确说当前业务已超越报告期。 关键点:管理层是否明确表示“报告期数字不代表当前业务”?没有直接表述。他们提到积压订单和定价,但这是对未来业绩的预期,而非对报告期数字的否定。报告期数字是实际结果,管理层并未说这些数字过时,而是说未来会更好。因此,不符合“报告期数字已过时”的表述。 结论:管理层没有传达出报告期结果不代表当前业务的信息。他们只是常规地讨论业绩和展望。因此答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| NBTX | Nanobiotix S.A. | Q2 2023 | 2023-09-27 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| VRE | Veris Residential, Inc. | Q4 2022 | 2023-02-22 | D |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OWL | Blue Owl Capital Inc. | Q2 2021 | 2021-08-10 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
VRE · Q4 2022 → YESThe question is: Does management convey that the reported results for the period do not represent the business the company is actually running today? That the just-reported numbers describe a company ...YES The transcript shows management repeatedly framing the reported period as transitional and not reflective of the current business: the shift to a pure-play multi-family company has already reduced office and hotel exposure while driving multi-family NOI share to 98%, with Haus25 leased at 95% ahead of schedule and same-store NOI guidance of 4-6% for 2023. They explicitly note that earnings variability stems from the ongoing asset sales and reallocation, with the business now positioned for growth as the transformation concludes, and they highlight post-period activity like additional sales and stabilized properties to underscore that the reported numbers capture a pre-transition state.
PFE · Q4 2023 → YESThe question is: Does management convey that the reported results do not represent the business the company is actually running today? That the just-reported numbers describe a company that has alread...NO The transcript shows management framing 2023 results as a challenging year with declines driven by COVID products, while positioning 2024 as a year of execution and growth through new priorities like the Seagen acquisition (closed late in 2023 with minimal contribution) and new product launches. This is a standard results-and 2024 outlook discussion, with forward-looking elements on pipeline, margins, and capital allocation rather than indicating the reported period is stale relative to current operations.
PRIM · Q2 2018 → YESThe question is whether management conveys that the reported results for Q2 2018 do not represent the business the company is actually running today. Specifically, if the printed period is stale relat...YES The transcript shows management repeatedly framing the Q2 results as a partial picture due to the late June 1 acquisition of Willbros. They note the business is "running as planned," highlight one-month revenue contribution of $1.